Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04451551
Other study ID # 15O-H2O PET Cohort
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 23, 2020
Est. completion date August 1, 2036

Study information

Verified date January 2023
Source University of Aarhus
Contact Simon Madsen, MD
Phone 4520140596+
Email simmas@rm.dk
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The trial will include 5000 patients with evident or suspected ischemic heart disease refered to Department of Nuclear Medicine & PET Centre, Aarhus University Hospital, for perfusion imaging by 15O-H2O PET/CT scan of the heart during rest and stress. The patients will undergo the clinical scan as normal. Data from the scans will be used to determine reference values of the examination. Follow up will be done for up to 10 years in regards to major cardiovascular events in order to determine the prognostic value of the scan.


Recruitment information / eligibility

Status Recruiting
Enrollment 5000
Est. completion date August 1, 2036
Est. primary completion date August 1, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Known or suspected ischemic heart disease referred for a clinical H2O-PET at Department of Nuclear Medicine and PET Centre, Aarhus University Hospital Exclusion Criteria: - Claustrophobia, severe asthma, younger than 18 years

Study Design


Locations

Country Name City State
Denmark Aarhus University Hospital Aarhus Aarhus N

Sponsors (1)

Lead Sponsor Collaborator
University of Aarhus

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prognostic value within 10 years Number of participants who experience a major adverse cardiac event within 10 years of follow-up. 10 years
Secondary Myocardial blood flow The myocardial blood flow of participants assessed by 15O-H2O PET/CT 5 Years
Secondary Coronary flow reserve The coronary flow reserve of participants assessed by 15O-H2O PET/CT 5 Years
Secondary Pulmonary transit time The pulmonary transit time of participants assessed by 15O-H2O PET/CT 5 Years
Secondary Left ventricular end-systolic volume The left ventricular end-systolic volume of participants assessed by 15O-H2O PET/CT 5 Years
Secondary Left ventricular end-diastolic volume The left ventricular end-diastolic volume of participants assessed by 15O-H2O PET/CT 5 Years
Secondary Right ventricular end-systolic volume The right ventricular end-systolic volume of participants assessed by 15O-H2O PET/CT 5 Years
Secondary Right ventricular end-diastolic volume The right ventricular end-diastolic volume of participants assessed by 15O-H2O PET/CT 5 Years
Secondary Immediate coronary angiography followup Number of participants who undergo coronary angiography within 3 months after primary 15O-H2O PET/CT 5 years
Secondary Immediate percutaneous coronary intervention (PCI) followup Number of participants who undergo percutaneous coronary intervention within 3 months after primary 15O-H2O PET/CT 5 years
Secondary Immediate coronary artery bypass graft (CABG) followup Number of participants who undergo coronary artery bypass graft within 3 months after primary 15O-H2O PET/CT 5 years
Secondary Prognostic value within 5 years Number of participants who experience a major adverse cardiac event within 5 years of follow-up. 5 years
Secondary Prognostic value within 2 years Number of participants who experience a major adverse cardiac event within 2 years of follow-up. 2 years
Secondary Prognostic value within 1 years Number of participants who experience a major adverse cardiac event within 1 years of follow-up. 1 years
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Active, not recruiting NCT04562805 - Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT) N/A
Recruiting NCT05292079 - CAPTURER PMCF Study ( rEPIC04D )
Recruiting NCT05292092 - Essential Pro PMCF Study ( rEPIC04E )
Recruiting NCT05292014 - ANGIOLITE PMCF Study ( rEPIC04F )
Recruiting NCT05292118 - Navitian PMCF Study ( rEPIC04C )
Completed NCT05292105 - NC Xperience PMCF Study( rEPIC04B)
Completed NCT03076801 - Does Choral Singing Help imprOve Stress in Patients With Ischemic HeaRt Disease? N/A
Not yet recruiting NCT04153383 - Milrinone on Cardiac Performance During Off-pump Coronary Artery Bypass Surgery
Recruiting NCT02729064 - Intraoperative Nasal Insulin Effect on Plasma and CSF Insulin Concentration and Blood Glucose Phase 1
Recruiting NCT02982434 - The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation Phase 2
Completed NCT02468401 - Prevention of Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions N/A
Completed NCT02759406 - Evaluation of the Palmaz Mach-5 Grooved Bare Metal Coronary Stent System Versus the Palmaz Bare Metal Coronary Stent System in Patients With Symptomatic Ischemic Heart Disease: A Safety and Performance Study N/A
Recruiting NCT01681381 - Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary Revascularization N/A
Completed NCT01699802 - Influence of Inhaled Anaesthetics on Rebreathing of Carbon Dioxide When Using an Anaesthesia Gas Reflector (AnaConDa) N/A
Completed NCT01604213 - Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery Disease Phase 4
Completed NCT01334268 - RESOLUTE China RCT N/A
Completed NCT01724567 - Copenhagen Study of Obese Patients With Ischemic Heart Disease Undergoing Low Energy Diet or Interval Training N/A
Completed NCT02159235 - Heavy Metals, Angiogenesis Factors and Osteopontin in Coronary Artery Disease (CAD) N/A